Bacitracin; polymyxin b sulfate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bacitracin; polymyxin b sulfate and what is the scope of patent protection?
Bacitracin; polymyxin b sulfate
is the generic ingredient in one branded drug marketed by Combe and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for bacitracin; polymyxin b sulfate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | bacitracin; polymyxin b sulfate at DailyMed |
Recent Clinical Trials for bacitracin; polymyxin b sulfate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Glaxo Wellcome | N/A |
National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for bacitracin; polymyxin b sulfate
US Patents and Regulatory Information for bacitracin; polymyxin b sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combe | LANABIOTIC | bacitracin; polymyxin b sulfate | DISC;TOPICAL | 050598-001 | Sep 22, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |